Who owns COLLPLANT BIOTECHNOLOGIES LT?
- Ticker: CLGN
- CUSIP Number: m2r51x116
Tip: Access positions for across all investors
Analyze quarterly positions in Collplant Biotechnologies Lt with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Collplant Biotechnologies Lt stock
Who bought or sold COLLPLANT BIOTECHNOLOGIES LT this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gail Mannix | 468k | $3.0M | -2% | Dec 2023 |
|
| St. Denis J. Villere & Co | 361k | $2.3M | 20% | Dec 2023 |
|
| Brown Advisory Holdings Incorporated | 75k | $478k | 0% | Dec 2023 |
|
| Benjamin F. Edwards & Company | 50k | $320k | 11% | Dec 2023 |
|
| Zurcher Kantonalbank | 23k | $148k | 0% | Dec 2023 |
|
| Citadel Advisors | 10k | $65k | 100% | Dec 2023 |
|
| Bank of America Corporation | 7.3k | $47k | 0% | Dec 2023 |
|
| Pnc Financial Services | 3.6k | $23k | 0% | Dec 2023 |
|
| FNY Investment Advisers | 1.5k | $9.0k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 371.00 | $2.4k | 100% | Dec 2023 |
|
| National Bank Of Canada /fi/ | 250.00 | $1.5k | 0% | Dec 2023 |
|
| Focused Wealth Management | 242.00 | $1.5k | 0% | Dec 2023 |
|
Who sold out of Collplant Biotechnologies Lt?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Sep 2023 | 5.7k | $32k |
| Geneos Wealth Management | Sep 2023 | 750.00 | $4.2k |